Strokes after transient ischemic attacks have declined over time, study shows
February 9, 2021
Patients should be monitored for an extended period after transient ischemic attacks.
New England Journal of Medicine publishes COVID-19 treatment trial results
January 27, 2021
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health found that a combination of the drugs baricitinib and remdesivir reduced time to recovery.
President’s message: Take a virtual tour of the new Barshop Institute
January 27, 2021
UT Health San Antonio is pleased to now have the Sam and Ann Barshop Institute for Longevity and Aging Studies located in the South Texas Medical Center, adjacent to the South Texas Research Facility and the Medical Arts and Research Center.
Journal article reviews century of data showing COVID-19 likely to impact the brain
January 19, 2021
An article published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association cites decades of published scientific evidence to make a compelling case for SARS-CoV-2’s expected long-term effects on the brain and nervous system.
Novavax COVID-19 vaccine trial opens at UT Health San Antonio, University Health
January 7, 2021
San Antonians will have the opportunity to participate in the fifth international COVID-19 vaccine clinical trial beginning in January. Locally, 500 participants are being sought.
Drinking alcohol blocks a chemical that promotes attention
December 22, 2020
In a new paper, researchers from UT Health San Antonio report brain chemistry that may contribute to why drinkers have difficulty paying attention while under the influence.
